Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China flag China · Delayed Price · Currency is CNY
20.85
-0.42 (-1.97%)
Nov 6, 2026, 10:25 AM CST

SHA:605177 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
204.33243.97513.18711.12501.58556.1
Short-Term Investments
-84.9317.83177.9--
Trading Asset Securities
8012050-3050
Cash & Short-Term Investments
284.33448.89581.01889.03531.58606.1
Cash Growth
-24.47%-22.74%-34.65%67.24%-12.29%-38.74%
Accounts Receivable
136.28184.79178.1209.59159.39128.89
Other Receivables
5.096.534.761.451.421.65
Receivables
141.38191.33182.85211.03160.81130.54
Inventory
363.67537.18720.57621.06482.84419.33
Prepaid Expenses
----1.08-
Other Current Assets
121.3416.0544.5225.9412.4216.45
Total Current Assets
910.721,1931,5291,7471,1891,172
Property, Plant & Equipment
1,7771,9001,7441,3521,011834.88
Long-Term Investments
49.9280.69148.28150.64181.4610
Other Intangible Assets
67.3859.8760.0661.8562.9745.15
Long-Term Deferred Tax Assets
75.3150.832.8912.5312.910.52
Long-Term Deferred Charges
55.2451.7333.9410.824.313.89
Other Long-Term Assets
11.521.748.098.5910.5174.21
Total Assets
2,9473,3383,5573,3432,4722,251

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
283.19369.77731.77520.12411.09406.25
Accrued Expenses
26.345.9437.2740.8337.0224.65
Short-Term Debt
66.88228.6298.94120.0795.01-
Current Portion of Long-Term Debt
24.373.779.1-0.02-
Current Portion of Leases
-2.912.983.823.63-
Current Income Taxes Payable
14.385.7606.799.493.64
Current Unearned Revenue
19.3511.9410.363.238.419.41
Other Current Liabilities
12.8722.1923.133.195.025.34
Total Current Liabilities
447.34690.89913.55698.05569.69449.29
Long-Term Debt
792.15752.33677.24576.4315-
Long-Term Leases
6.096.574.86.629.12.38
Long-Term Unearned Revenue
76.5581.8785.8446.236.7140.47
Long-Term Deferred Tax Liabilities
--0.160.460.67-
Other Long-Term Liabilities
0.210.330.270.320.790.85
Total Liabilities
1,3221,5321,6821,328631.95492.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
114.71114.73114.75113.6113.6113.6
Additional Paid-In Capital
1,1361,1301,1181,1291,1291,129
Retained Earnings
269.24466.67549.06686.3597.99516.31
Treasury Stock
-9.98-20.29-20.55-30--
Comprehensive Income & Other
115.39114.73113.18116.72-0.48-0.48
Total Common Equity
1,6251,8061,8752,0151,8401,758
Minority Interest
--0.12---
Shareholders' Equity
1,6251,8061,8752,0151,8401,758
Total Liabilities & Equity
2,9473,3383,5573,3432,4722,251

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
889.49994.2793.06706.93122.762.38
Net Cash (Debt)
-605.16-545.31-212.05182.1408.82603.72
Net Cash Growth
----55.46%-32.28%-38.36%
Net Cash Per Share
-5.29-4.77-1.901.463.605.29
Filing Date Shares Outstanding
114.5112.93108.61111.43113.6113.6
Total Common Shares Outstanding
114.5112.93108.61112.58113.6113.6
Working Capital
463.38502.56615.41,049619.04723.13
Book Value Per Share
14.1915.9917.2617.9016.2015.48
Tangible Book Value
1,5581,7461,8151,9531,7771,713
Tangible Book Value Per Share
13.6015.4616.7117.3515.6415.08
Buildings
-1,126632.03545.94454.64410.59
Machinery
-1,4061,1891,084878.92723.64
Construction In Progress
-170.74599.8296.55157.09114.87